ClinFlows recently participated in Bio-Europe in Stockholm, the EANM Congress (European Association of Nuclear Medicine) in Vienna, and MEDICA in Düsseldorf — key events that have advanced the company’s knowledge on current imaging trends, AI and innovative solutions in oncology and orthopedics.
“Cancer and orthopedic treatments require thorough evaluation and absolute precision, something that image transfer via our decidemedical platform can surely support ,” says Uwe Gladbach, CEO and founder of ClinFlows. “By directly engaging with industry leaders at these congresses, we align the use of our software solutions with the evolving needs of specialists in these fields and thereby contribute to better patient care.”